Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 41 trials
Active filters
Clinical trials found
Published and searchable clinical trials
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
NCT07121946
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma ( FL), +18 more
- Locations
-
- City of Hope Duarte, California, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center - Bergen New York, United States
NCT07680933
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
CAR-T Followed by Bispecific Antibodies
NCT04889716
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
NCT07249905
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DLBCL - Diffuse Large B Cell Lymphoma, +28 more
- Locations
-
- Epworth HealthCare Richmond, Victoria, Australia
- Linear Clinical Research Nedlands, Western Australia, Australia
NCT07548697
- Conditions
- B-cell Non Hodgkin Lymphoma (NHL), DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +14 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
SynKIR-310 for Relapsed/Refractory B-NHL
NCT06544265
- Conditions
- Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
- Locations
-
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- The University of Kansas Cancer Center Fairway, Kansas, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
NCT06481826
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT06846463
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell Lymphoma, +13 more
- Locations
-
- Virginia Commonwealth University Richmond, Virginia, United States
DALY II Japan/MB-CART2019.1 for DLBCL
NCT07288879
- Conditions
- CAR T Cell Therapy, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +6 more
- Locations
-
- National Cancer Center Hospital Tokyo, Japan
- Toranomon Hospital Tokyo, Japan
- Juntendo University Hospital Tokyo, Japan
- Tokyo Metropolitan Komagome Hospital Tokyo, Japan
NCT06220032
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +22 more
- Locations
-
- NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands
- NL-Almelo-ZGTALMELO Almelo, Netherlands
- NL-Amstelveen-AMSTELLAND Amstelveen, Netherlands
- NL-Apeldoorn-GELREAPELDOORN Apeldoorn, Netherlands
NCT06736613
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, +21 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta
NCT05950802
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT07255963
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT05940272
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Memorial Sloan Kettering Cancer Center (All protocol activities) New York, United States
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only) New York, United States
NCT07057765
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University Cairo, Cairo Governorate, Egypt
NCT06891157
- Conditions
- Chidamide, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +8 more
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
NCT06151080
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma, +12 more
- Locations
-
- Bing Xu Xiamen, Fujian, China
NCT06158399
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Bing Xu Xiamen, Fujian, China
NCT06026488
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
NCT05641428
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- NL-Amsterdam-AMC Amsterdam, Netherlands
- NL-Groningen-UMCG Groningen, Netherlands
- NL-Leiden-LUMC Leiden, Netherlands
- NL-Maastricht-MUMC Maastricht, Netherlands